The Network held its fall cycle of the INVENT Kickstarter Awards in September. After receiving several highly competitive applications, three studies have been selected to receive INVENT Kickstarter funding.
Award Winners
- Dr. M. Di Nisio of the TRIP Network has been awarded $15,000 to open the REDUCE study in the Dutch Thrombosis Network in collaboration with Dr. Floris T.M. Bosch at the Amsterdam University Medical Center. REDUCE is a prospective cohort study assessing the Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients.
- Dr. Grégoire Le Gal of the CanVECTOR Network has been awarded $15,000 to open ADJUST-DVT in the INNOVTE Network in collaboration with Dr. Moustafa Fares at the CHU Gabriel-Montpied, Pôle Urgences. ADJUST-DVT is a prospective outcome study assessing an Age-adjusted D-dimer cut-off levels to rule out deep vein thrombosis.
- Dr.Lana Castellucci of the CanVECTOR Network has been awarded $15,000 to open the COBRRA trial in the THANZ Network in collaboration Dr. Vivien Chen at the Concord Hospital in Sydney Australia. COBRRA is a Phase 4 multicentre RCT assessing the Comparison of bleeding Risk between Rivaroxaban and Apixaban.
In total, the Kickstarter awards will involve collaboration among four INVENT National VTE Networks with the aim of helping investigator-initiated studies complete recruitment in a more timely manner. Conducting clinical research in multiple countries offers the advantages of faster participant recruitment and study completion, and greater generalizability of results.
About INVENT Kickstarter Awards
The network and its partners have established the INVENT Kickstarter Awards to provide funding to support international study expansion of INVENT Endorsed Studies. These funds are intended to help Principal Investigators of academic studies endorsed by the network to initiate new international sites at INVENT-member countries.
The goal is to support international collaboration by providing funding to enable start-up activities that are not covered by the primary funding for the study.
The next award cycle will be in Spring 2020. Stay tuned!